New research from NYU Langone Medical Center shows that a simple, inexpensive and noninvasive carotid artery ultrasound of the neck can be used as a preliminary diagnostic tool for coronary artery disease (CAD). This may be an alternative to the standard, expensive and more invasive coronary angiography. The ultrasound test can also be used to rule out the diagnosis of CAD in patients presenting with reduced heart pump function. The new study appears in the June 2010 issue of the American Heart Journal.
"Our research has identified that carotid artery ultrasound is capable of identifying the presence of severe and extensive coronary artery disease," said Harmony R. Reynolds, MD, assistant professor of Medicine and associate director of the Cardiovascular Clinical Research Center at NYU Langone Medical Center. "Based on our findings, physicians might consider using the carotid ultrasound test as an initial screen for CAD in patients with reduced heart pump function and no history of heart attack. If a patient tests positive for plaque buildup in the neck arteries, then it can be followed by angiography of the heart arteries."
When a patient has reduced heart function, severe and extensive CAD is often the cause. CAD is a narrowing of the arteries in the heart caused by deposits of plaque. This condition reduces the flow of blood and oxygen to the heart and may lead to weakening of heart muscle and/or a heart attack.
source: EurekAlert
Monday, June 14, 2010
Carotid artery ultrasound is an effective alternative to more invasive coronary angiography
Thursday, June 10, 2010
Thyroid Ultrasound Takes Center Stage at Caesars Palace
LAUREL , MD - June 8, 2010 – The American Institute of Ultrasound in Medicine (AIUM) and the American Association of Clinical Endocrinologists (AACE) are collaborating to present Thyroid and Parathyroid Imaging and Update on Thyroid Disorders, July 31–August 1, at Caesars Palace in Las Vegas, Nevada. During this continuing medical education event, endocrinologists, radiologists, sonographers, and other health care providers interested in thyroid/parathyroid imaging will be updated on the growing applications of sonography in the evaluation of thyroid and parathyroid disease.
“Ultrasound has become a significant tool to examine thyroid and parathyroid glands, stage thyroid cancer, and guide biopsies and procedures,” said course cochair Daniel Duick, MD. “These capabilities are allowing for greatly improved patient care, and practitioners need to be up-to-date.”
The course will incorporate live scanning demonstrations and presentations from experts in neck sonography, endocrinology, radiology, pathology, and endocrine surgery.
source: AIUM
Tuesday, June 1, 2010
SonoSite Announces Definitive Agreement to Acquire Visualsonics
SonoSite, Inc. /quotes/comstock/15*!sono/quotes/nls/sono (SONO 29.03, -0.06, -0.21%) , the world leader and specialist in bedside and point-of-care ultrasound, today announced that it has signed an agreement to acquire privately held Visualsonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology. The aggregate transaction value will be approximately $71 million net of cash and debt.
Visualsonics is the technology leader in real-time ultra high-frequency micro-ultrasound that presently serves the rapidly growing pre-clinical research market. Founded in 1999 by Stuart Foster, Ph.D., at Sunnybrook Health Sciences Center, Visualsonics' micro-ultrasound technology uses five times the center frequency range currently used in conventional ultrasound systems (40MHz versus 8MHz) and enables the visualization of superficial anatomy on small living animals with microscopic detail, discerning features as small as 40 microns (versus conventional ultrasound, which visualize 200 microns). Visualsonics' technology has the potential to pave the way for a new era of extreme high-resolution ultrasound imaging of superficial anatomy in clinical medicine.
source: MarketWatch
Tuesday, May 25, 2010
Boston Scientific Announces Collaborations on Cardiovascular Imaging Technology With Philips and Siemens
NATICK, Mass., May 24 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced collaborations with Philips Healthcare and Siemens Medical Solutions to enable the use of its iLab® Ultrasound Imaging System with the Philips Allura™ Xper and the Siemens AXIOM™ Artis and Artis™ zee interventional X-ray systems. Intravascular ultrasound (IVUS) technology is designed to provide physicians a 360-degree view inside the heart and coronary vessels to assist with diagnosis and to generate a more accurate image of the diseased vessels than is possible with angiography alone.
Boston Scientific's collaborations with Philips and Siemens include recently completed compatibility testing, which confirmed that the iLab System can function as an integrated system with the Philips and Siemens X-ray systems. The Company previously announced a similar collaboration with GE Healthcare and its Innova® System. The iLab System is designed to be installed directly into a cardiac catheterization laboratory or radiology suite alongside these X-ray systems, enabling physicians to more readily incorporate IVUS technology into their procedures. The integrated systems will be featured at the annual EuroPCR Scientific Program, May 25 – 28 in Paris.
"Boston Scientific is proud to work with Philips and Siemens to offer integrated imaging systems that support improvements in performance, workflow and ease of use," said Joe Fitzgerald, Senior Vice President and President of Boston Scientific's Endovascular Unit. "Cath labs worldwide can now integrate the iLab Ultrasound Imaging System with the vast majority of interventional X-ray systems."
source: PR Newswire
Friday, May 21, 2010
Siemens Showcases Advanced 3D Imaging and Software Applications at ACOG 2010
San Francisco, Ca., May 17, 2010 – Featuring advanced clinical applications that bring OB/GYN imaging to the next level, Siemens Healthcare will showcase its exclusive syngo®.fourSight™ Workplace* image management software at the 58th Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists (ACOG) in San Francisco. Siemens will highlight a comprehensive selection of the latest innovations in OB/GYN imaging, including a new 3D immersive imaging experience using professional graphics solutions.
With Siemens’ new syngo.fourSight Workplace, volume imaging takes on a whole new dimension with true stereoscopic views of 3D images delivering a 3D imaging experience more immersive, detailed and real-to-life than ever before. Conventional 3D ultrasound technologies use two-dimensional monitors for the evaluation of 3D images. The combination of NVIDIA® 3D Vision™ technology, NVIDIA Quadro® FX high-end professional graphics solutions and syngo.fourSight Workplace, based on NVIDIA CUDA™ architecture, offers the experience of 3D imaging in “real 3D.”
“This takes 3D/4D ultrasound imaging to the next level,” said Dr. Norbert Gaus, CEO, Clinical Products Division, Siemens Healthcare. “It offers a truly remarkable experience that’s rewarding for parents and their doctors.”
Leveraging NVIDIA visualization technology, Siemens Ultrasound offers a vastly improved overall ultrasound experience. “syngo.fourSight Workplace is a cost-effective, cutting-edge solution that we believe will be embraced by both physicians and their patients. It is an excellent example of how modern 3D technology is being utilized for professional applications such as medical imaging,” said Jeff Brown, general manager, NVIDIA Professional Solutions.
source: Siemens Medical
Wednesday, May 5, 2010
High Resolution Ultrasound: First-Line Imaging Choice for the Evaluation of Patients With Foot Drop?
High resolution ultrasound should be the imaging test of choice when evaluating patients with foot drop (an inability or difficulty in moving the ankle and toes causing uncontrolled slapping of the foot while taking a step), according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA. Ultrasound imaging is non-invasive and involves exposing part of the body to high-frequency ultrasound waves to produce pictures of inside the body.
Foot drop is usually caused by peroneal neuropathy which is the most common compression neuropathy (damage to a single nerve or nerve group) of the lower extremity. “Electromyography (EMG) and magnetic resonance imaging (MRI) are commonly used to evaluate the peroneal nerve in patients with foot drop, however, they are not always effective,' said Tom Grant, DO, lead author of the study.
The study, performed at the Feinberg School of Medicine, Northwestern University, in Chicago, IL, included 15 patients with foot drop who were evaluated using high resolution ultrasound. “Ultrasound was found to be highly effective for the characterization of the common peroneal nerve, including intrinsic and extrinsic causes of peroneal neuropathy,” said Grant. All patients evaluated were found to have peroneal neuropathy.
“Ultrasound is less expensive than EMG and MRI, it is painless, and as our study suggests, is highly effective for the evaluation of patients with foot drop,” he said.
source: American Roentgen Ray Society
Sunday, May 2, 2010
New Free Hand Ultrasound System Improves Work Flow and Reduces Scan Time
Researchers have developed an automated 3-D mapping and labeling system that reduces scan time and improves the work flow, efficiency, and accuracy of routine freehand ultrasound exams, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
“The labeling and measuring of free hand ultrasound images are operator dependent, time consuming, and are usually manually performed,” said Calin Caluser, MD, lead author of the study. “The new 3-D mapping and labeling system that we have developed automatically records information and replaces steps in the image acquisition process (that are typically performed manually) with a simple key stroke,” said Caluser.
The study measured the timing and accuracy of the new system in a realistic breast ultrasound phantom with small masses scattered throughout. “Results showed that the average scanning time per target using the new mapping and labeling system was up to 16 seconds per target; compared to at least 51 seconds per target using the standard scanning protocol. The system accurately measured and recorded the location of the masses in relation to the nipple (up to 2 mm), which is difficult to obtain using the manual method,” said Caluser.
“The new system can be added to any existing ultrasound machine and the reduced time for scanning the patient can translate in improved work flow and efficiency,” he said.
source: ARRS
Tuesday, April 20, 2010
EDAP Receives European Approval for New Sonolith i-move Lithotripsy Device
LYON, France, Apr 12, 2010 (GlobeNewswire via COMTEX) -- EDAP TMS SA /quotes/comstock/15*!edap/quotes/nls/edap (EDAP 3.15, +0.00, +0.03%) , the global leader in therapeutic ultrasound, announced today the European approval of its new lithotripter, the Sonolith i-move. The EDAP sales team and distributors will begin marketing Sonolith i-move immediately and will officially introduce the product to distributors, partners and visiting urologists at the European Association Urology (EAU) congress, Booth #14, from April 17-19, 2010 in Barcelona, Spain.
Leveraging EDAP's patented electroconductive technology, Sonolith i-move is a compact, stand alone lithotripter with a revolutionary infrared stereo-vision system for real-time, three-dimensional ultrasound localization of urinary stones. With its various modular configurations, Sonolith i-move targets the largest lithotripsy market segment, offering a wide range of treatment procedures for mid-size clinical sites and hospitals. Sonolith i-move will replace Sonolith Praktis, an earlier generation lithotripter, and complements the Company's high-end Sonolith I-sys lithotripter, an integration of x-ray and ultrasound locatization systems.
In addition to the official launch in Europe, EDAP is actively working towards filing for regulatory approval of Sonolith i-move in the U.S. and in Japan.
source: MarketWatch
Wednesday, April 7, 2010
Simple ultrasound test improves diagnosis of heart disease
New research shows that doing a simple ultrasound scan of the carotid artery significantly improves the prediction of heart disease, giving doctors a better clue of who is at high risk for a heart attack.
The new study, published in today’s Journal of the American College of Cardiology (JACC), shows that approximately 23 percent of patients would be reclassified into a different risk group by adding information obtained from the noninvasive test and that risk prediction using this approach was more accurate.
"Today, up to 70 percent of people who have heart attacks are in a low or intermediate risk category for a heart attack when their risk is estimated using traditional risk prediction models. That’s not very predictive, and we need to do better," said Dr. Christie Ballantyne, director of the Center for Cardiovascular Disease Prevention at the Methodist DeBakey Heart & Vascular Center and Baylor College of Medicine in Houston and last author on the study. "Our research shows that a noninvasive ultrasound can give us a more complete snapshot of our patients’ risk, so we can do a better job determining if they’ll have a heart attack."
This is significant because patients who are at higher risk could be treated more aggressively to prevent heart disease.
source: Houston Mehtodist Hospital
Monday, April 5, 2010
Groundbreaking Whole Breast, Warm Bath Ultrasound Technology Is Producing Promising Results
SALT LAKE CITY, March 30 /PRNewswire-FirstCall/ -- TechniScan, Inc.'s (OTC Bulletin Board: TSNI) unique whole breast ultrasound technology, which provides a comfortable, radiation-free method for assessment of breast lesions was part of a scientific presentation at the National Consortium of Breast Centers (NCBC) conference in Las Vegas last week.
Yuri Parisky, radiologist, vice president and trustee of the NCBC organization and consultant to TechniScan, Inc. participated in the Orange County, CA research study that was presented at the conference. The objective of the study was to determine the usability of the new Warm Bath Ultrasound (TM) technology in a standard breast diagnostic practice. The study found that the groundbreaking technology used in TechniScan's Warm Bath Ultrasound (WBU) produced promising results and indicated that it may have a future role in the evaluation of breast lesions.
"Ultrasound technology is playing a larger role in breast diagnostics because it images cysts, fibroadenomas and cancers differently than mammography. Ultrasound is much better at seeing through dense breasts and finding cancers when they are smaller," said Parisky. "The emergence of whole breast ultrasound technology and specifically the WBU system is providing us with 3-D images of the entire breast, and will hopefully become a standard imaging modality in the next few years."
TechniScan's Warm Bath Ultrasound system is designed to capture three-dimensional images of the breast as a woman lies prone on a table and state-of-the art ultrasound technology is used in a warm water tank to capture images of the breast anatomy.
source: PR Newswire
Sunday, March 28, 2010
GE Healthcare Introduces New Ultrasound Elastography Capability
SAN DIEGO, CA, MARCH 24, 2010 ― GE Healthcare (NYSE: GE) today announced that an important new feature has been added to its LOGIQ E9 platform; elastography. The enhanced device is on display at the American Institute of Ultrasound in Medicine’s (AIUM) 2010 Annual Convention in San Diego (booth 301).
GE’s LOGIQ E9 introduces ultrasound elastography utilizing a high frequency E-series transducer with a simple compression technique which helps make elastography easier to perform and a more reproducible method of examination.
“Physicians have traditionally examined differences in tissue by hand palpation during physical exams,” said Brian McEathron, general manager of General Imaging Ultrasound, GE Healthcare. “The LOGIQ E9 helps give doctors a digital interpretation of the physical exam that can be easier to reproduce in follow-up examinations by either the original physician or other clinicians.”
LOGIQ E9 elastography is a tool that helps provide a gentle way to obtain information about internal tissue structures and has the potential to assist in patient management decisions, increase diagnostic confidence and help lead to fewer invasive procedures.
source: GE Healthcare
Thursday, March 18, 2010
Unique Guideline Demonstrates A Multi-Specialty Outlook For Musculoskeletal Ultrasound
The AIUM is pleased to announce that 4 professional societies have collaborated with AIUM to endorse the recent AIUM Training Guidelines for the Performance of Musculoskeletal Ultrasound Examinations. The guidelines allow for a several practitioners, including physicians, osteopathic physicians, podiatrists, and sonographers, to perform musculoskeletal ultrasound examinations, marking significant promise for the future of this growing field.
The American Academy of Physical Medicine and Rehabilitation, American Medical Society for Sports Medicine, American Podiatric Medical Association, and Musculoskeletal Ultrasound Society have provided official support/endorsement for the guidelines to date.
source: Medical News Today
Wednesday, March 17, 2010
Toshiba Highlights Ultrasound Cardiac Capabilities At ACC 2010
ATLANTA, March 16, 2010 – Health care facilities use ultrasound as a first-line diagnostic exam to quickly and efficiently perform a range of patient exams, including cardiac imaging. Developed to meet these demanding clinical needs, Toshiba America Medical Systems, Inc. will showcase the advanced cardiac capabilities of its AplioTM MX and Aplio ArtidaTM ultrasound systems at this year’s American College of Cardiology (ACC) annual meeting in Atlanta, March 14 – 16, 2010 (Booth # 1944). This is the first appearance of the Aplio MX at ACC.
Introduced in November 2009, Toshiba’s new Aplio MX ultrasound system is a mid-sized, cart-based system that improves patient care by offering increased portability and patient access, with the ability to perform premium ultrasound exams using this smaller system. The functional Aplio MX allows physicians to quickly and efficiently perform a range of advanced ultrasound exams, including cardiac, on patients when space is limited, such as in the emergency department, intensive care unit, outside the lab and at the patient’s bedside.
Features of the Aplio MX include:
• Contrast Harmonics to provide the ability to use bubble based contrast agents that help to provide better tissue definition on difficult-to-image patients during echocardiograms.
• Differential Tissue Harmonic Imaging for the better imaging of difficult-to-image patients, like bariatric, without sacrificing resolution to give superior border and tissue definition.
• ApliPure+ to enhance both image clarity and detail definition with real-time compounding technology to simultaneously perform spatial and frequency compounding during transmitting and receiving.
• Advanced Dynamic Flow to provide color Doppler imaging at an unprecedented level and show flow with directional information for even the smallest vessels.
• Tissue Doppler Imaging Quantification (TDIQ) software to perform various analyses by Angle Corrected Displacement and Strain to measure myocardial viability.
source: Toshiba Medical
Monday, March 15, 2010
GE Healthcare Introduces New Ultrasound Needle Tracking Capability
NewswireToday - /newswire/ - Tampa, FL, United States, 03/15/2010 - LOGIQ E9’s new volume navigation feature includes electromagnetic needle tip sensor for improved guidance accuracy.
GE Healthcare (NYSE: GE) today announced an important new onboard feature to its LOGIQ E9 platform – needle tracking powered by GE’s innovative Volume Navigation capability. The enhanced device is on display at the Society for Interventional Radiology’s 35th Annual Scientific Meeting (booth 620).
With the extraordinary image quality of the LOGIQ E9, this new Volume Navigation needle tracking capability with its sensor tipped needle helps overcome many of the traditional challenges of existing ultrasound needle guidance such as needle visualization and deflection, determining entry points and the avoidance of critical anatomy. This, in turn, can help increase the accuracy of procedures such as biopsies, ablations, drainage, fluid aspiration and general injections.
“LOGIQ E9’s advanced needle tracking can now help medical professionals utilize ultrasound during in-plane and challenging out-of-plane interventional procedures,” said Brian McEathron, general manager of General Imaging Ultrasound, GE Healthcare. “This can reduce time, limit repeat procedures, improve outcomes and result in a better overall patient experience.”
Before the skin is even penetrated, the LOGIQ E9’s advanced technology projects the path to the target, helping to plan the optimal angle and point of entry. During the procedure, the system displays the needle’s position in real-time graphics that are overlaid on the image of the scan plane. The trajectory can then be monitored as it progresses toward the target.
source: Newswire
Friday, March 12, 2010
TechniScan teams with researchers at UC San Diego in clinical study with Warm Bath UltrasoundTM system
SALT LAKE CITY (March 9, 2010) -- TechniScan, Inc. (OTC BB: TSNI) (“TechniScan” or the “Company”), a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, today announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center.
TechniScan’s Warm Bath Ultrasound (WBU™) system is designed to capture three-dimensional images of the breast as a woman lies prone on a table and state-of-the- art ultrasound technology is used in a warm water tank to capture images of the breast anatomy.
The Moores UCSD Cancer Center is a National Cancer Institute (NCI) designated comprehensive cancer center with scientists and clinicians focused on developing the next generation of cancer therapies and cures. The TechniScan Warm Bath UltrasoundTM system investigations will be conducted with Michael P. Andre, Ph.D., Professor of Radiology, and breast radiologists Dr. Linda Olson and Dr. Haydee Ojeda-Fournier.
source: Techniscan
Saturday, March 6, 2010
SonoSite's NanoMaxx Ultrasound System Selected as a Finalist for the 2010 Edison Best New Product Awards
BOTHELL, Wash., Mar 04, 2010 (BUSINESS WIRE) -- SonoSite, Inc. /quotes/comstock/15*!sono/quotes/nls/sono (SONO 31.08, +0.32, +1.04%) , the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that the 6 lb. NanoMaxx(TM) ultrasound system was selected as a finalist for the prestigious Edison Best New Product Awards. The awards are inspired by the enormous contributions of renowned inventor Thomas Edison and honor significant achievements in new product development, marketing, and innovation.
SonoSite's NanoMaxx system is an extremely portable, high-resolution imaging tool that provides point-of-care visualization to a variety of medical specialties. Empowering physicians to meet the highest standard of patient care, the NanoMaxx system targets applications that will improve patient safety and minimize complications. With one-dial control, advanced proprietary imaging algorithms, a 20 second boot-up time, and a rugged form factor (successfully drop-tested from three feet), the NanoMaxx system is a breakthrough technology that truly meets an unmet clinical need.
The Edison Award finalists were selected by a rigorous peer-reviewed voting system, which comprised of an estimated 2,000 members of not-for-profit Marketing Executives Network Group (MENG), America's top executives, and academic researchers.
source: MarketWatch